Princeton gender studies program to offer 'sex work,' 'queer spaces' courses
STRATA Skin Sciences ( NASDAQ:SSKN – Get Free Report ) and Delcath Systems ( NASDAQ:DCTH – Get Free Report ) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, profitability, earnings and analyst recommendations. Institutional and Insider Ownership 32.4% of STRATA Skin Sciences shares are owned by institutional investors. Comparatively, 61.1% of Delcath Systems shares are owned by institutional investors. 39.0% of STRATA Skin Sciences shares are owned by company insiders. Comparatively, 17.9% of Delcath Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Volatility and Risk STRATA Skin Sciences has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Comparatively, Delcath Systems has a beta of 0.75, meaning that its share price is 25% less volatile than the S&P 500. Analyst Recommendations Delcath Systems has a consensus target price of $21.50, indicating a potential upside of 120.29%. Given Delcath Systems’ stronger consensus rating and higher probable upside, analysts plainly believe Delcath Systems is more favorable than STRATA Skin Sciences. Earnings & Valuation This table compares STRATA Skin Sciences and Delcath Systems”s gross revenue, earnings per share and valuation. STRATA Skin Sciences has higher revenue and earnings than Delcath Systems. Delcath Systems is trading at a lower price-to-earnings ratio than STRATA Skin Sciences, indicating that it is currently the more affordable of the two stocks. Profitability This table compares STRATA Skin Sciences and Delcath Systems’ net margins, return on equity and return on assets. Summary STRATA Skin Sciences beats Delcath Systems on 8 of the 14 factors compared between the two stocks. About STRATA Skin Sciences ( Get Free Report ) STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania. About Delcath Systems ( Get Free Report ) Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company’s lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York. Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter .
Acres commercial realty sees $51,650 in stock sales by Eagle PointWall Street slips to a rare back-to-back loss
WASHINGTON (AP) — In the two weeks since Donald Trump won the presidency, he's tried to demonstrate his dominance by naming loyalists for top administration positions, even though many lack expertise and some face sexual misconduct accusations. It often seems like he's daring Congress to oppose his decisions. But on Thursday, Trump's attempt to act with impunity showed a crack as Matt Gaetz , his choice for attorney general, withdrew from consideration. Trump had named Gaetz, a Florida congressman, to be the country's top law enforcement official even though he was widely disliked by his colleagues, has little legal experience and was accused of having sex with an underage girl, an allegation he denied. After being plagued by investigations during his first presidency, Trump wanted a devoted ally in charge of the Justice Department during his second. However, it was never obvious that Gaetz could win enough support from lawmakers to get confirmed as attorney general. Trump chose for a replacement Pam Bondi, a former Florida attorney general who defended him during his first impeachment trial and supported his false claims of voter fraud. Now the question is whether Gaetz was uniquely unpalatable, or if Trump's other picks might exceed his party's willingness to overlook concerns that would have sunk nominees in a prior political era. The next test will likely be Pete Hegseth, who Trump wants to lead the Pentagon despite an allegation of sexual assault that he's denied. So far, Republicans are rallying around Hegseth , an Army veteran and former Fox News host. Sen. Thom Tillis, a North Carolina Republican who serves on the Senate Judiciary Committee, said the controversy over Gaetz would have little bearing on Trump’s other choices. He said they would be considered “one at a time.” Sen. Richard Blumenthal, a Connecticut Democrat, suggested otherwise, claiming “the dominoes are falling.” “The drip drip of evidence and truth is going to eventually doom some others,” he said. Trump's election victory was a sign that there may not be many red lines left in American politics. He won the presidential race despite authoritarian, racist and misogynist rhetoric, not to mention years of lies about election fraud and his role in sparking the Jan. 6, 2021, attack on the U.S. Capitol. He was also criminally convicted of falsifying business records to pay hush money, and he was found liable for sexual abuse in a civil case. Empowered by voters who looked past his misconduct and saw him as a powerful agent of change, Trump has shown no deference to Washington norms while working to fill his second administration . The transition team hasn't pursued federal background checks for Trump's personnel choices. While some of his selections have extensive experience in the areas they've been chosen to lead, others are personal friends and Fox News personalities who have impressed and flattered Trump over the years. Several have faced allegations involving sexual misconduct . Hegseth is facing the most scrutiny after Gaetz. Once Trump announced Hegseth as his nominee for Pentagon chief, allegations emerged that he sexually assaulted a woman in California in 2017. The woman said he took her phone, blocked the door to the hotel room and refused to let her leave, according to a police report made public this week. Hegseth told police at the time that the encounter had been consensual and denied any wrongdoing, the report said. However, he paid the woman a confidential settlement in 2023. Hegseth's lawyer said the payment was made to head off the threat of a baseless lawsuit. Trump’s choice for secretary of health and human Services, Robert F. Kennedy Jr., has faced allegations of misconduct too. A woman who babysat for him and his second wife told Vanity Fair magazine that Kennedy groped her in the late 1990s, when she was 23. Kennedy did not deny the allegation and texted an apology to the woman after the article was published. That isn't the only hurdle for Kennedy; he's spent years spreading misinformation and conspiracy theories about vaccines, raising fears about making him a top health official in the new administration. Linda McMahon, chosen by Trump to be education secretary, is fighting a lawsuit connected to her former company, World Wrestling Entertainment. She’s accused of knowingly enabling sexual exploitation of children by an employee as early as the 1980s, and she denies the allegations. Tulsi Gabbard is another person who could face a difficult confirmation battle, but for very different reasons. The former Democratic representative from Hawaii has been a vocal Trump ally, and he chose her to be national intelligence director. But there's grave concern by lawmakers and national security officials over Gabbard’s history of echoing Russian propaganda. Critics said she would endanger relationships with U.S. allies. Gaetz was investigated by federal law enforcement for sex trafficking, but the case was closed without charges and Republicans have blocked the release of a related report from the House Ethics Committee. However, some allegations leaked out, including that Gaetz paid women for sex. One of the women testified to the committee that she saw Gaetz having sex with a 17-year-old girl, according to a lawyer for the woman. As Gaetz met with senators this week, it became clear that he would face stubborn resistance from lawmakers who were concerned about his behavior and believed he was unqualified to run the Justice Department. “While the momentum was strong, it is clear that my confirmation was unfairly becoming a distraction,” Gaetz wrote on social media when announcing his withdrawal. Sen. Mike Braun, an Indiana Republican, said he believed there were four to six members of the caucus who would have voted against Gaetz, likely dooming his nomination, and “the math got too hard.” He said some of the issues and allegations around Gaetz were “maybe beyond the pale." “I think there were just too many things, it was like a leaky dike, and you know, it broke," Braun said. Trump thanked Gaetz in a post on Truth Social, his social media website, without addressing the substance of the allegations against him. “He was doing very well but, at the same time, did not want to be a distraction for the Administration, for which he has much respect,” Trump wrote. Associated Press writers Mary Clare Jalonick, Stephen Groves and Lisa Macaro contributed from Washington. Jill Colvin in New York and Adriana Gomez Licon in Fort Lauderdale, Florida, also contributed.While they might not be producing a wealth of offense, the Kings have been penurious defensively of late and will take that stinginess northward to San Jose for a matchup with the Sharks on Monday. They surrendered just one goal in each contest during their three-game homestand and no five-on-five markers, most recently restraining the Seattle Kraken in a 2-1 win. Seattle had won five of its past six games, whereas San Jose has dropped six of its past seven. David Rittich, who has made three straight starts since Darcy Kuemper sustained his second lower-body injury of the young campaign during a loss in Colorado, has posted six one-goal-allowed efforts in 11 starts, with five of those performances being wins. The sixth was a 1-0 loss to Buffalo on Wednesday, which coach Jim Hiller said he thought gave the Kings additional motivation against Seattle. “I think we played really well the last couple (games), but (against Seattle) we did something extra with obviously scoring goals, which gives us the opportunity to win,” Rittich said. Individual Kings had plenty of motivation, too. Their second-period power-play goal represented the first point in seven games for Kevin Fiala and the first goal in six for Quinton Byfield, as well as the first power-play goal by any King against a goalie in the past seven games. Byfield’s scoring woes have been longer-standing. Byfield said he’d like to better integrate the physical side of his game into his offense, but for now was pleased to have broken through, and with an authoritative snipe, no less. “It’s obviously tough. You do think about it, but you’ve got to stay positive. I’ve learned from the best, Kopi, all the time he’s just even keel,” said Byfield, referring to Kings captain Anze Kopitar. “I try to be happy, that’s just my personality. I don’t want to bring anyone else down around me. It always comes eventually, and hopefully it’ll pile up.” Saturday also marked Byfield’s 200th career game, and he joined seven other players who have crossed that threshold from his 2020 draft class. He accumulated those games across parts of five seasons, some of which saw him bounce between the NHL and AHL while he also battled serious injuries and illnesses. “It was tough. There was a lot of adversity and a lot of challenging moments in those 200 games,” Byfield said. There might not be a ton of adversity ahead for the Kings in San Jose, given that the Sharks remain in a half-decade-long rebuild still waiting to take off and have been mired in a funk lately, too. But the Kings managed to lose to them and another bottom-dweller, the Chicago Blackhawks, in the same week, and their 4-2 loss in San Jose on Oct. 29 featured an 0-for-6 display on the power play. Five days earlier, the Kings had beaten the Sharks, 3-2, in L.A. The No. 1 overall pick in the 2024 draft, Macklin Celebrini, did not compete in either meeting for San Jose. He’ll be healthy Monday and has scored seven points in 10 games, production spearheaded by three multi-point outings. Veteran Mikael Granlund’s 24 points are eight more than any other Shark has contributed this season.
Unisys Appoints Michael M. Thomson as Chief Executive OfficerPathstone Holdings LLC Cuts Position in FactSet Research Systems Inc. (NYSE:FDS)
From wealth and success to murder suspect, the life of Luigi Mangione took a hard turnHow much do you need to worry about a stock-market crash? More than a little. - MarketWatch